VOYA Investment Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,282
| Closed | -$27.5K | – | 2754 |
|
|
2025
Q1 | $27.5K | Sell |
17,282
-39,735
| -70% | -$63.2K | ﹤0.01% | 2602 |
|
|
2024
Q4 | $173K | Buy |
57,017
+7,058
| +14% | +$21.4K | ﹤0.01% | 2435 |
|
|
2024
Q3 | $184K | Buy |
49,959
+30,716
| +160% | +$113K | ﹤0.01% | 2507 |
|
|
2024
Q2 | $78.7K | Sell |
19,243
-125,380
| -87% | -$513K | ﹤0.01% | 2728 |
|
|
2024
Q1 | $2.28M | Sell |
144,623
-4,232
| -3% | -$66.7K | ﹤0.01% | 1309 |
|
|
2023
Q4 | $2.26M | Buy |
148,855
+38,753
| +35% | +$587K | ﹤0.01% | 1330 |
|
|
2023
Q3 | $2.21M | Buy |
110,102
+3,780
| +4% | +$75.8K | ﹤0.01% | 1295 |
|
|
2023
Q2 | $3M | Buy |
106,322
+88,558
| +499% | +$2.5M | ﹤0.01% | 1196 |
|
|
2023
Q1 | $306K | Hold |
17,764
| – | – | ﹤0.01% | 2318 |
|
|
2022
Q4 | $358K | Hold |
17,764
| – | – | ﹤0.01% | 2218 |
|
|
2022
Q3 | $385K | Buy |
17,764
+3,452
| +24% | +$74.8K | ﹤0.01% | 2193 |
|
|
2022
Q2 | $402K | Hold |
14,312
| – | – | ﹤0.01% | 1971 |
|
|
2022
Q1 | $660K | Buy |
14,312
+292
| +2% | +$13.5K | ﹤0.01% | 1746 |
|
|
2021
Q4 | $1.18M | Buy |
14,020
+226
| +2% | +$19K | ﹤0.01% | 1442 |
|
|
2021
Q3 | $919K | Buy |
13,794
+733
| +6% | +$48.8K | ﹤0.01% | 1629 |
|
|
2021
Q2 | $695K | Buy |
13,061
+513
| +4% | +$27.3K | ﹤0.01% | 1892 |
|
|
2021
Q1 | $544K | Buy |
12,548
+599
| +5% | +$26K | ﹤0.01% | 1984 |
|
|
2020
Q4 | $621K | Buy |
+11,949
| New | +$621K | ﹤0.01% | 1777 |
|